| 1. Kasutani K, Fujii E, Ohyama S, Adachi H, Hasegawa M, Kitamura H, Yamashita N. (2014) Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice.. Br J Pharmacol, 171 (22): (5049-58). [PMID:24946165] [10.1021/op500134e] |
| 2. Kabashima K, Matsumura T, Komazaki H, Kawashima M, Nemolizumab-JP01 Study Group. (2020) Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.. N Engl J Med, 383 (2): (141-150). [PMID:32640132] [10.1021/op500134e] |
| 3. Kabashima K, Furue M, Hanifin JM, Pulka G, Wollenberg A, Galus R, Etoh T, Mihara R, Nakano M, Ruzicka T. (2018) Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.. J Allergy Clin Immunol, 142 (4): (1121-1130.e7). [PMID:29753033] [10.1021/op500134e] |
| 4. Nemoto O, Furue M, Nakagawa H, Shiramoto M, Hanada R, Matsuki S, Imayama S, Kato M, Hasebe I, Taira K et al.. (2016) The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study.. Br J Dermatol, 174 (2): (296-304). [PMID:26409172] [10.1021/op500134e] |
| 5. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J et al.. (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.. Nat Immunol, 5 (7): (752-60). [PMID:15184896] [10.1021/op500134e] |
| 6. Ghilardi, Nico N and 5 more authors.. (2002) A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5.. The Journal of biological chemistry, (10): [PMID:11877449] |
| 7. Diveu, Caroline C and 14 more authors.. (2003) GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor.. The Journal of biological chemistry, (12): [PMID:14504285] |
| 8. Dreuw, Alexandra A and 5 more authors.. (2004) Characterization of the signaling capacities of the novel gp130-like cytokine receptor.. The Journal of biological chemistry, (20): [PMID:15194700] |
| 9. Diveu, Caroline C and 8 more authors.. () Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling.. European cytokine network, [PMID:15627637] |
| 10. Bilsborough, Janine J and 10 more authors.. (2006) IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.. The Journal of allergy and clinical immunology, [PMID:16461143] |
| 11. Jawa, Randeep S RS and 6 more authors.. (2008) Regulated expression of the IL-31 receptor in bronchial and alveolar epithelial cells, pulmonary fibroblasts, and pulmonary macrophages.. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, [PMID:18439099] |
| 12. Lin, Ming-Wei MW and 16 more authors.. (2010) Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.. European journal of human genetics : EJHG, [PMID:19690585] |
| 13. Kasraie, Sadaf S, Niebuhr, M M, Baumert, K K and Werfel, T T.. (2011) Functional effects of interleukin 31 in human primary keratinocytes.. Allergy, [PMID:21261663] |
| 14. Cevikbas, Ferda F and 17 more authors.. (2014) A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.. The Journal of allergy and clinical immunology, [PMID:24373353] |
ZJ24F0303672